|9.90|| +0.26 / +2.70%|
CryoLife, Inc. is a medical devices company, which preserved human cardiac and vascular tissues, surgical adhesives and sealants, cardiac lasers and implantable end-stage renal disease access grafts for the repair of complex cardiac and vascular reconstruction surgeries. It manufactures, distributes implantable living human tissues for use in cardiac and vascular surgeries. The company operates its business trough two segments: Medical Devices and Preservation Services. The Medical Devices segment includes marketing and distribution of BioGlue, BioFoam, PerClot, HemoStase and other. The Preservation Services segment preserves human cardiac and vascular tissue to implanting institutions throughout the United States, Canada and Europe. CryoLife was founded by Steven G. Anderson on January 19, 1984 and is headquartered in Kennesaw, GA.
|James Patrick Mackin||Chairman, President & Chief Executive Officer|
|David Ashley Lee||Executive VP, Chief Operating & Financial Officer|
|Scott B. Capps||Vice President-Clinical Research|
|David C. Gale||Vice President-Research & Development|
|Jean F. Holloway||Secretary, Vice President & General Counsel|